The choreography of cyclooxygenases in the kidney.
作者信息
FitzGerald G A
机构信息
Center for Experimental Therapeutics, School of Medicine, 153 Johnson Pavillion, 3620 Hamilton Walk, University of Pennsylvania, Philadelphia, PA 19104-6084, USA.
出版信息
J Clin Invest. 2002 Jul;110(1):33-4. doi: 10.1172/JCI16044.
Abstract
摘要
相似文献
1
The choreography of cyclooxygenases in the kidney.
J Clin Invest. 2002 Jul;110(1):33-4. doi: 10.1172/JCI16044.
2
[New anti-inflammatory analgetics--are they needed?].
Duodecim. 1999;115(20):2217-24.
3
[The cardiovascular safety of cyclooxygenase-2 (COX-2) inhibitors].
Harefuah. 2002 Oct;141(10):922-4.
4
[Safe use of anti-inflammatory analgesics].
Duodecim. 2003;119(22):2167-71.
5
[NSAIDs for therapy of rheumatoid arthritis. Introduction].
Nihon Rinsho. 2005 Jan;63 Suppl 1:473-6.
6
The coxibs, selective inhibitors of cyclooxygenase-2.
N Engl J Med. 2001 Aug 9;345(6):433-42. doi: 10.1056/NEJM200108093450607.
7
[Current status of study on selective cyclooxygenase-2 inhibitors and evaluation of its application].
Di Yi Jun Yi Da Xue Xue Bao. 2002 Feb;22(2):184-6.
8
Microsomal prostaglandin E2 synthase: a safer target than cyclooxygenases?
Mol Interv. 2007 Aug;7(4):195-9, 180. doi: 10.1124/mi.7.4.5.
9
Do non-steroidal anti-inflammatory drugs and COX-2 selective inhibitors have different renal effects?
J Nephrol. 2002 Sep-Oct;15(5):480-8.
10
[The use of non-steroidal anti inflammatory drugs (NSAIDs)--COX-2 inhibitors].
Harefuah. 2002 Oct;141(10):920-1.
引用本文的文献
1
Influence of variability in the cyclooxygenase pathway on cardiovascular outcomes of nephrosclerosis patients.
Sci Rep. 2023 Jan 23;13(1):1253. doi: 10.1038/s41598-022-27343-z.
2
Glomerular Biomechanical Stress and Lipid Mediators during Cellular Changes Leading to Chronic Kidney Disease.
Biomedicines. 2022 Feb 9;10(2):407. doi: 10.3390/biomedicines10020407.
3
The Cardiovascular Pharmacology of Nonsteroidal Anti-Inflammatory Drugs.
Trends Pharmacol Sci. 2017 Aug;38(8):733-748. doi: 10.1016/j.tips.2017.05.008. Epub 2017 Jun 23.
4
Hyperfiltration-associated biomechanical forces in glomerular injury and response: Potential role for eicosanoids.
Prostaglandins Other Lipid Mediat. 2017 Sep;132:59-68. doi: 10.1016/j.prostaglandins.2017.01.003. Epub 2017 Jan 17.
5
Use of NSAIDs in treating patients with arthritis.
Arthritis Res Ther. 2013;15 Suppl 3(Suppl 3):S2. doi: 10.1186/ar4174. Epub 2013 Jul 24.
6
Prostaglandin E(2) is crucial in the response of podocytes to fluid flow shear stress.
J Cell Commun Signal. 2010 Jun;4(2):79-90. doi: 10.1007/s12079-010-0088-9. Epub 2010 Apr 8.
7
Cyclooxygenase-2-dependent prostacyclin formation and blood pressure homeostasis: targeted exchange of cyclooxygenase isoforms in mice.
Circ Res. 2010 Feb 5;106(2):337-45. doi: 10.1161/CIRCRESAHA.109.204529. Epub 2009 Nov 25.
8
Prostaglandin F2alpha elevates blood pressure and promotes atherosclerosis.
Proc Natl Acad Sci U S A. 2009 May 12;106(19):7985-90. doi: 10.1073/pnas.0811834106. Epub 2009 Apr 24.
9
Cardiomyocyte cyclooxygenase-2 influences cardiac rhythm and function.
Proc Natl Acad Sci U S A. 2009 May 5;106(18):7548-52. doi: 10.1073/pnas.0805806106. Epub 2009 Apr 17.
10
Cyclooxygenases, microsomal prostaglandin E synthase-1, and cardiovascular function.
J Clin Invest. 2006 May;116(5):1391-9. doi: 10.1172/JCI27540. Epub 2006 Apr 13.
本文引用的文献
1
Opposite effects of cyclooxygenase-1 and -2 activity on the pressor response to angiotensin II.
J Clin Invest. 2002 Jul;110(1):61-9. doi: 10.1172/JCI14752.
2
A comparison of adverse renovascular experiences among osteoarthritis patients treated with rofecoxib and comparator non-selective non-steroidal anti-inflammatory agents.
Curr Med Res Opin. 2002;18(2):82-91. doi: 10.1185/030079902125000354.
3
Role of prostacyclin in the cardiovascular response to thromboxane A2.
Science. 2002 Apr 19;296(5567):539-41. doi: 10.1126/science.1068711.
4
Relative risk of cardiovascular events in patients with rheumatoid arthritis.
Am J Cardiol. 2002 Mar 21;89(6A):33D-38D. doi: 10.1016/s0002-9149(02)02235-x.
5
Deficiency of COX-1 causes natriuresis and enhanced sensitivity to ACE inhibition.
Kidney Int. 2001 Dec;60(6):2324-9. doi: 10.1046/j.1523-1755.2001.00072.x.
6
The coxibs, selective inhibitors of cyclooxygenase-2.
N Engl J Med. 2001 Aug 9;345(6):433-42. doi: 10.1056/NEJM200108093450607.
7
Up-regulation of endothelial cyclooxygenase-2 and prostanoid synthesis by platelets. Role of thromboxane A2.
J Biol Chem. 2001 Oct 12;276(41):37839-45. doi: 10.1074/jbc.M010606200. Epub 2001 Aug 1.
8
Coupling between cyclooxygenase, terminal prostanoid synthase, and phospholipase A2.
J Biol Chem. 2001 Sep 14;276(37):34918-27. doi: 10.1074/jbc.M100429200. Epub 2001 Jun 19.
9
Why there are two cyclooxygenase isozymes.
J Clin Invest. 2001 Jun;107(12):1491-5. doi: 10.1172/JCI13271.
10
Renal safety and tolerability of celecoxib, a novel cyclooxygenase-2 inhibitor.
Am J Ther. 2000 May;7(3):159-75. doi: 10.1097/00045391-200007030-00004.
Zotero 插件